Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035074
Filing Date
2022-11-03
Accepted
2022-11-03 21:47:46
Documents
2
Period of Report
2022-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1515
2 EX-24 DOCUMENT attachment1.htm EX-24 3567
  Complete submission text file 0000899243-22-035074.txt   6554
Mailing Address C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Elam Nevan C (Reporting) CIK: 0001314773 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39951 | Film No.: 221359986

Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Issuer) CIK: 0001834645 (see all company filings)

EIN.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)